The new pattern of drug abuse in China

Current Opinion in Psychiatry

Volumn 27, Issue 4, 2014, Pages 251-255

  Sun, Hong Qiang ^a   Bao, Yan Ping ^b   Zhou, Shuang Jiang ^c   Meng, Shi Qiu ^a   Lu, Lin ^a,b  

^a PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c BEIJING HUILONGGUAN HOSPITAL   (China)

Author keywords

China; comorbidity; drug abuse; epidemiology; intervention

Indexed keywords

AMPHETAMINE; DESIGNER DRUG; DIAMORPHINE; ILLICIT DRUG; OPIATE;

CHINA; CHINESE; COGNITIVE THERAPY; COMORBIDITY; DRUG ABUSE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG TRAFFIC; FAMILY THERAPY; HARM REDUCTION; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); MULTIPLE DRUG ABUSE; OPIATE ADDICTION; PSYCHOSIS; REVIEW; SEXUALLY TRANSMITTED DISEASE; TREND STUDY; SUBSTANCE-RELATED DISORDERS;

CHINA; DESIGNER DRUGS; HUMANS; SUBSTANCE-RELATED DISORDERS;

EID: 84901836777     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0000000000000073     Document Type: Review

References (43)

1. Liu Z, Lian Z, Zhao C. Drug use and HIV/AIDS in China. Drug Alcohol Rev 2006; 25:173-175.
2. Tang YL, Zhao D, Zhao C, Cubells JF. Opiate addiction in China: current situation and treatments. Addiction 2006; 101:657-665.
3. Bao YP, Liu ZM. Current situation and trends of drug abuse and HIV/AIDS in China. HIV Ther 2009; 3:237-240.
4. Office of China National Narcotic Control Commission (2013) 2013 Annual Report on Drug Control in China. Beijing, China: Office of China National Narcotic Control Commission, http://www.mps.gov.cn/n16/n80209/n80481/n804535/ 3815337.html. [Accessed 7 June 2013]
5. National surveillance center on drug abuse (2012) 2012 Annual report on drug abuse in China. Beijing, China: National surveillance center on drug abuse, China Food and Drug Administration, http://www.sda.gov.cn/WS01/CL0051/93340. html. [Accessed 17 October 2013]
6. National surveillance center on drug abuse (2011) 2011 Annual report on drug abuse in China. Beijing, China: National surveillance center on drug abuse, China Food and Drug Administration.
7. Fang YX, Wang YB, Shi J, et al. Recent trends in drug abuse in China. Acta Pharmacol Sin 2006; 27:140-144.
8. Lu L, Zhao D, Bao YP, Shi J. Methadone maintenance treatment of heroin abuse in China. Am J Drug Alcohol Abuse 2008; 34:127-131.
9. State Council HIV/AIDS Working Committee Office, UN Theme Group on HIV/AIDS in China (2011) A Joint Assessment of HIV/AIDS Prevention, Treatment and Care in China. Beijing, China: State Council HIV/AIDS Working Committee Office, UN Theme Group on HIV/AIDS in China.
10. Bu PB, Duan MY, Lv F, Liu YH. Analysis of HIV/AIDS related behavior surveillance survey among drug users in Health Project Nine province. Chin J AIDS STD 2009; 5:263-265.
11. Yi CY, Zhao BC, Ling K, et al. Study on the status of HIV infection and influencing factors among drug users with methadone maintenance treatment. Pract Prevent Med 2013; 20:432-434.
12. Sun HQ, Chen HM, Yang FD, et al. Epidemiological trends and the advances of treatments of amphetamine-type stimulants (ATS) in China. Am J Addict 2014; 23:313-317.
13. Zhang Y, Lu C, Zhang J, et al. Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China. Addict Behav 2013; 38:1424-1430.
14. Bao YP, Liu ZM, Lian Z, et al. Prevalence and correlates of HIV and HCV infection among amphetamine-type stimulant users in 6 provinces in China. J Acquir Immune Defic Syndr 2012; 60:438-446.
15. Bao YP, Qiu Y, Yan SY, et al. Pattern of drug use and depressive symptoms among amphetamine type stimulants users in Beijing and Guangdong pro vince, China. PLoS One 2013; 8:e60544.
16. State Council HIV/AIDS Working Committee Office, UN Theme Group on HIV/AIDS in China (2012) A Joint Assessment of HIV/AIDS Prevention, Treatment and Care in China (2012). Beijing, China: State Council HIV/AIDS Working Committee Office, UN Theme Group on HIV/AIDS in China. This is the updated report on HIV/AIDS in China.
17. National Health and Family Planning Commission of the People's Republic of China (2009) Guidelines of Diagnostic and Treatment on ATS use.
18. Chen SQ, Zhai HF. Poly-drug use, a common drug abuse model. Chin J of Drug Abus Prev and Treat 2010; 16:334-339.
19. Wubuli A. Investigation of poly-drug use characterstic and model among heroin addicts in five area in China. Beijing: Peking University; 2009.
20. Liu ZM, Zhou WH, Lian Z, Cao JQ. Epidemiological survey on poly-drug abuse among drug addicts. Chin J Clin Pharmacol 2000; 16:272-276.
21. Gu N. Analysis of polydrug abuse in 478 heroin dependent patients. Chin J Drug Depend 2011; 20:225-227.
22. Liu YH, Li Y, Xu W. The research for polydrug abuse among one hundred and sixty nine community-based methadone maintenance treatment patients. Chin J Drug Depend 2013; 22:303-306.
23. Wang Q, Liu XY, Wu B, Z JY. Risk factors for drug abuse among middle school students in Shenzhen. Chin J Sch Health 2013; 34:275-276.
24. Ma Y, Li ZZ, Zhang KX. Identification of HIV infection among drug users in China. Chin J Epidemiol 1990; 11:184-185.
25. State Council HIV/AIDS Working Committee Office, UN Theme Group on HIV/AIDS in China (2004) A Joint Assessment of HIV/AIDS Prevention, Treatment and Care in China (2004). Beijing, China: State Council HIV/AIDS Working Committee Office, UN Theme Group on HIV/AIDS in China.
26. Bao YP, Liu ZM. Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS 2009; 20:399-405.
27. Bao YP, Liu ZM, Lu L. Review of HIV and HCV infection among drug users in China. Curr Opin Psychiatry 2010; 23:187-194.
28. Liu ZM, Cao JQ, Lv XX, Lian Z. Epidemiological study of central stimulants and other related psychoactive substance abuse. Chin J Drug Depend 2002; 11:286-293.
29. Zweben JE, Cohen JB, Christian D, et al. Psychiatric symptoms in metham-phetamine users. Am J Addict 2004; 13:181-190.
30. Sutcliffe CG, German D, Sirirojn B, et al. Patterns of methamphetamine use and symptoms of depression among young adults in northern Thailand. Drug Alcohol Depend 2009; 101:146-151.
31. The central people's government of the People's Republic of China (2008) Anti-Drug Law of the People's Republic of China.
32. The central people's government of the People's Republic of China (2011) The Regulation on Drug Rehabilitation of the People's Republic of China.
33. The central people's government of the People's Republic of China (2005) The Regulations on the Administration of Precursor Chemicals of the People's Republic of China.
34. Wu Z, Sullivan SG, Wang Y, et al. Evolution of China's response to HIV/AIDS. Lancet 2007; 369:679-690.
35. Sullivan SG, Wu Z. Rapid scale up of harm reduction in China. Int J Drug Policy 2007; 18:118-128.
36. Wu Z, Sun X, Sullivan SG, Detels R. Public health. HIV testing in China. Science 2006; 312:1475-1476.
37. Drug Administration Bureau of Ministry of Health. Guideline of medications for opiate addiction. Beijing, China: Drug Administration Bureau of Ministry of Health; 1993.
38. Liu ZM, Lv XX, Lian Z. Evaluation on drug dependence of buprenorphine. Acta Pharmacologica Sinica 2003; 24:448-452.
39. Liu TT, Shi J, Epstein DH, et al. A meta-analysis of Chinese herbal medicine in treatment of managed withdrawal from heroin. Cell Mol Neurobiol 2009; 29:17-25.
40. Li XD, Li WP, Xu RH, Li R. Efficacy of maintenance treatment with bupre-norphine sublingual tablets for relapse prevention among heroin addicts. Chin J Drug Depend 2009; 15:401-405.
41. Wu HF, Yang MB. A family-style drug abuse treatment and rehabilitation program. Chin J of Drug Abus Prev and Treat 2002; 8:4-6.
42. Tang YL. Rehabilitation program for drug addiction in correctional institutions. Chin J Drug Depend 2001; 10:27-29.
43. Zhao M, Young DS, Hao W, et al. TC-based rehabilitation program in the treatment of heroin addicts in correction camps. Chin J Drug Depend 2000; 9:213-216.